Liver-specific deceased donor risk indices

Hepatology Research

Volumn 44, Issue 2, 2014, Pages 159-164

  Wang, Zifa ^a,b   Hisatake, Garrett ^a   Yang, Libin ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Anti hepatitis B core positive donors; Hepatic artery variations; Hepatitis C virus positive allografts; Liver steatosis; Liver transplantation

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ALLOGRAFT; ANATOMICAL VARIATION; ARTICLE; BRAIN DEATH; COLD ISCHEMIA; FAT CONTENT; FATTY LIVER; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERNATREMIA; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; RISK ASSESSMENT; SURGEON;

EID: 84893726097     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12228     Document Type: Article

References (46)

1. Braat AE, Blok JJ, Putter H etal. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant 2012; 12: 2789-2796.
2. Bacchella T, Galvão FH, Jesus de Almeida JL, Figueira ER, de Moraes A, César Machado MC. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J 2008; 126: 161-165.
3. Feng S, Goodrich NP, Bragg-Gresham JL etal. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
4. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-425.
5. Rana A, Hardy MA, Halazun KJ etal. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537-2546.
6. Bonney GK, Aldersley MA, Asthana S etal. Donor risk index and MELD interactions in predicting long-term graft survival: a single center experience. Transplantation 2009; 87: 1858-1863.
7. Palmiero HO, Kajikawa P, Boin IF, Coria S, Pereira LA. Liver recipient survival rate before and after model for end-stage liver disease implementation and use of donor risk index. Transplant Proc 2010; 42: 4113-4115.
8. Blok JJ, Braat AE, Adam R etal. Validation of the donor risk index (DRI) in orthotopic liver transplantation within the eurotransplant region. Liver Transpl 2012; 18: 112-119.
9. Marsman H, Matsushita T, Dierkhising R etal. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004; 35: 430-435.
10. McCormack L, Clavien PA. Understanding the meaning of fat in the liver. Liver Transpl 2005; 11: 137-139.
11. Nocito A, El-Badry AM, Clavien PA. When is steatosis too much for transplantation? J Hepatol 2006; 45: 494-499.
12. McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol 2011; 54: 1055-1062.
13. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105-113.
14. Dutkowski P, Schlegel A, Slankamenac K etal. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg 2012; 256: 861-868.
15. Deroose JP, Kazemier G, Zondervan P, Ijzermans JN, Metselaar HJ, Alwayn IP. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB 2011; 13: 417-425.
16. Doyle MB, Vachharajani N, Wellen JR etal. Short- and long-term outcomes after steatotic liver transplantation. Arch Surg 2010; 145: 653-660.
17. McCormack L, Petrowsky H, Jochum W etal. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940-948.
18. Franzen LE, Ekstedt M, Kechagias S, Bodin L. Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 2005; 18: 912-916.
19. Fiorini RN, Kirtz J, Periyasamy B etal. Development of an unbiased method for the estimation of liver steatosis. Clin Transplant 2004; 18: 700-706.
20. El-Badry AM, Breitenstein S, Jochum W etal. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009; 250: 691-697.
21. Nadig SN, Bratton CF, Karp SJ. Marginal donors in liver transplantation: expanding the donor pool. J Surg Educ 2007; 64: 46-50.
22. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010; 52: 272-279.
23. Skagen CL, Jou JH, Said A. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis. Clin Transplant 2011; 25: E243-249.
24. Ju W, Chen M, Guo Z etal. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus. Exp Clin Transplant 2013; 11: 245-249
25. Saidi RF, Jabbour N, Shah SA, Li YF, Bozorgzadeh A. Liver transplantation from hepatitis B surface antigen-positive donors. Transplant Proc 2013; 45: 279-280.
26. Loggi E, Micco L, Ercolani G etal. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. J Hepatol 2012; 56: 579-585.
27. Jiang L, Yan L, Li B, Wen T etal. Successful use of hepatitis B surface antigen-positive liver grafts in recipients with hepatitis B virus-related liver diseases. Liver Transpl 2011; 17: 1236-1238.
28. Natov SN, Pereira BJG. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (part 2: hepatitis C virus). Transpl Infect Dis 2002; 4: 124-131.
29. Marelli D, Bresson J, Laks H etal. Hepatitis C-positive donors in heart transplantation. Am J Transplant 2002; 2: 443-447.
30. Ghobrial RM, Steadman R, Gornbein J etal. A 10- year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234: 384-393.
31. Velidedeoglu E, Desai NM, Campos L etal. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002; 73: 582-587.
32. Mandal AK, Kraus ES, Samaniego M etal. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant 2000; 14: 391-396.
33. Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 1343-1353.
34. López-Navidad A, Caballero F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003; 17: 308-324.
35. Cameron A, Busuttil RW. AASLD/ILTS transplant course: is there an extended donor suitable for everyone? Liver Transpl 2005; 11 (Suppl 2): S2-5.
36. Harring TR, O'Mahon CA, Goss JA. Extended donors in liver transplantation. Clin Liver Dis 2011; 15: 879-900.
37. Totsuka E, Fung U, Hakamada K etal. Analysis of clinical variables of donors and recipients with respect to short-term graft outcome in human liver transplantation. Transplant Proc 2004; 36: 2215-2218.
38. Kaseje N, Lüthold S, Mentha G etal. Donor hypernatremia influences outcomes following pediatric liver transplantation. Eur J Pediatr Surg 2013; 23: 8-13.
39. Mangus RS, Fridell JA, Vianna RM etal. Severe hypernatremia in deceased liver donors does not impact early transplant outcome. Transplantation 2010; 90: 438-443.
40. Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 1966; 112: 337-347.
41. Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 1994; 220: 50-52.
42. Cappadonna CR, Johnson LB, Lu AD, Kuo PC. Outcome of extra-anatomic vascular reconstruction in orthotopic liver transplantation. Am J Surg 2001; 182: 147-150.
43. López-Andújar R, Moya A, Montalvá E etal. Lessons learned from anatomic variants of the hepatic artery in 1, 081 transplanted livers. Liver Transpl 2007; 13: 1401-1404.
44. Molmenti EP, Klein AS, Henry ML. Procurement of liver and pancreas allografts in donors with replaced/accessory right hepatic arteries. Transplantation 2004; 78: 770-771.
45. Melada E, Maggi U, Rossi G etal. Back-table arterial reconstructions in liver transplantation: single-center experience. Transplant Proc 2005; 37: 2587-2588.
46. Soliman T, Bodingbauer M, Langer F etal. The role of complex hepatic artery reconstruction in orthotopic liver transplantation. Liver Transpl 2003; 9: 970-975.